Cargando…

Protective role of Kalpaamruthaa in type II diabetes mellitus-induced cardiovascular disease through the modulation of protease-activated receptor-1

BACKGROUND: Kalpaamruthaa (KA) is a formulatory herbal preparation has beneficial antioxidant, anti-apoptotic and anti-inflammatory properties against cardiovascular damage (CVD). OBJECTIVE: The present study was undertaken to investigate the protective role of KA in type II diabetes mellitus-induce...

Descripción completa

Detalles Bibliográficos
Autores principales: Latha, Raja, Shanthi, Palanivelu, Sachdanandam, Panchanadham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461962/
https://www.ncbi.nlm.nih.gov/pubmed/26109768
http://dx.doi.org/10.4103/0973-1296.157739
_version_ 1782375582533681152
author Latha, Raja
Shanthi, Palanivelu
Sachdanandam, Panchanadham
author_facet Latha, Raja
Shanthi, Palanivelu
Sachdanandam, Panchanadham
author_sort Latha, Raja
collection PubMed
description BACKGROUND: Kalpaamruthaa (KA) is a formulatory herbal preparation has beneficial antioxidant, anti-apoptotic and anti-inflammatory properties against cardiovascular damage (CVD). OBJECTIVE: The present study was undertaken to investigate the protective role of KA in type II diabetes mellitus-induced CVD through the modulation of protease-activated receptor-1 (PAR1). MATERIALS AND METHODS: CVD was developed in 8 weeks after type II diabetes mellitus induction with high fat diet (2 weeks) and low dose of streptozotocin (2 × 35 mg/kg b.w. i.p. in 24 h interval). CVD-induced rats treated with KA (200 mg/kg b.w. in 0.5 ml of olive oil) orally for 4 weeks. RESULTS: KA increased the activities of enzymatic antioxidants and the levels of non-enzymatic antioxidants in pancreas of CVD-induced rats. KA effectively reduced the lipid peroxides and carbonyl content in the pancreas of CVD-induced rats. KA reduced cellular damage by ameliorating the activities of marker enzymes in plasma, heart and liver. The protective nature of KA was further evidenced by histological observation in pancreas. Further, KA reduced CVD by decreasing the expression of PAR1 in heart. CONCLUSION: This study exhibits the defending role of KA in type II diabetes mellitus-induced CVD through altering PAR1.
format Online
Article
Text
id pubmed-4461962
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-44619622015-06-24 Protective role of Kalpaamruthaa in type II diabetes mellitus-induced cardiovascular disease through the modulation of protease-activated receptor-1 Latha, Raja Shanthi, Palanivelu Sachdanandam, Panchanadham Pharmacogn Mag Original Article BACKGROUND: Kalpaamruthaa (KA) is a formulatory herbal preparation has beneficial antioxidant, anti-apoptotic and anti-inflammatory properties against cardiovascular damage (CVD). OBJECTIVE: The present study was undertaken to investigate the protective role of KA in type II diabetes mellitus-induced CVD through the modulation of protease-activated receptor-1 (PAR1). MATERIALS AND METHODS: CVD was developed in 8 weeks after type II diabetes mellitus induction with high fat diet (2 weeks) and low dose of streptozotocin (2 × 35 mg/kg b.w. i.p. in 24 h interval). CVD-induced rats treated with KA (200 mg/kg b.w. in 0.5 ml of olive oil) orally for 4 weeks. RESULTS: KA increased the activities of enzymatic antioxidants and the levels of non-enzymatic antioxidants in pancreas of CVD-induced rats. KA effectively reduced the lipid peroxides and carbonyl content in the pancreas of CVD-induced rats. KA reduced cellular damage by ameliorating the activities of marker enzymes in plasma, heart and liver. The protective nature of KA was further evidenced by histological observation in pancreas. Further, KA reduced CVD by decreasing the expression of PAR1 in heart. CONCLUSION: This study exhibits the defending role of KA in type II diabetes mellitus-induced CVD through altering PAR1. Medknow Publications & Media Pvt Ltd 2015-05 /pmc/articles/PMC4461962/ /pubmed/26109768 http://dx.doi.org/10.4103/0973-1296.157739 Text en Copyright: © Pharmacognosy Magazine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Latha, Raja
Shanthi, Palanivelu
Sachdanandam, Panchanadham
Protective role of Kalpaamruthaa in type II diabetes mellitus-induced cardiovascular disease through the modulation of protease-activated receptor-1
title Protective role of Kalpaamruthaa in type II diabetes mellitus-induced cardiovascular disease through the modulation of protease-activated receptor-1
title_full Protective role of Kalpaamruthaa in type II diabetes mellitus-induced cardiovascular disease through the modulation of protease-activated receptor-1
title_fullStr Protective role of Kalpaamruthaa in type II diabetes mellitus-induced cardiovascular disease through the modulation of protease-activated receptor-1
title_full_unstemmed Protective role of Kalpaamruthaa in type II diabetes mellitus-induced cardiovascular disease through the modulation of protease-activated receptor-1
title_short Protective role of Kalpaamruthaa in type II diabetes mellitus-induced cardiovascular disease through the modulation of protease-activated receptor-1
title_sort protective role of kalpaamruthaa in type ii diabetes mellitus-induced cardiovascular disease through the modulation of protease-activated receptor-1
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461962/
https://www.ncbi.nlm.nih.gov/pubmed/26109768
http://dx.doi.org/10.4103/0973-1296.157739
work_keys_str_mv AT latharaja protectiveroleofkalpaamruthaaintypeiidiabetesmellitusinducedcardiovasculardiseasethroughthemodulationofproteaseactivatedreceptor1
AT shanthipalanivelu protectiveroleofkalpaamruthaaintypeiidiabetesmellitusinducedcardiovasculardiseasethroughthemodulationofproteaseactivatedreceptor1
AT sachdanandampanchanadham protectiveroleofkalpaamruthaaintypeiidiabetesmellitusinducedcardiovasculardiseasethroughthemodulationofproteaseactivatedreceptor1